Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2013. Upgrade now.
Date Value
March 31, 2024 -0.0011M
December 31, 2023 1.755M
September 30, 2023 -40.78M
June 30, 2023 -0.0034M
March 31, 2023 -0.0086M
December 31, 2022 2.406M
September 30, 2022 2.094M
June 30, 2022 1.529M
March 31, 2022 -0.1189M
December 31, 2021 -2.749M
September 30, 2021 0.0099M
June 30, 2021 -0.6522M
March 31, 2021 -1.164M
December 31, 2020 8.410M
September 30, 2020 -0.16M
June 30, 2020 -3.205M
March 31, 2020 4.099M
December 31, 2019 7.674M
September 30, 2019 8.880M
June 30, 2019 8.385M
March 31, 2019 -20.08M
December 31, 2018 -17.88M
September 30, 2018 -0.1655M
Date Value
June 30, 2018 -0.1965M
March 31, 2018 -0.1892M
December 31, 2017 9.381M
September 30, 2017 -4.886M
June 30, 2017 -0.1321M
March 31, 2017 4.753M
December 31, 2016 5.240M
September 30, 2016 5.305M
June 30, 2016 -0.5364M
March 31, 2016 -20.13M
December 31, 2015 -0.0696M
September 30, 2015 -0.1406M
June 30, 2015 -0.0555M
March 31, 2015 -0.0417M
December 31, 2014 -0.0385M
September 30, 2014 -0.3002M
June 30, 2014 -0.022M
March 31, 2014 -0.0356M
December 31, 2013 -0.015M
September 30, 2013 -0.0263M
June 30, 2013 -0.0616M
March 31, 2013 -0.1056M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

-40.78M
Minimum
Sep 2023
8.880M
Maximum
Sep 2019
-0.18M
Average
0.0044M
Median

Cash from Investing (Quarterly) Benchmarks

CureVac NV -5.527M
InflaRx NV 29.27M
MorphoSys AG --
BioNTech SE -2.503B
Immatics NV -262.66M